CytomX Therapeutics, Inc. (CTMX)
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.
Address
151 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA 94080
Founded
2010
Number of Employees
122
Website
http://www.cytomx.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)